Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| VIEMED HEALTHCARE, INC.VMD · Entity 5824 | Director · Chief Operating Officer | January 29, 2026 | February 02, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
VIEMED HEALTHCARE, INC.
Report date January 29, 2026 · Filed February 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common SharesSEC Table I · non-derivative | Direct | 390,309 |
Ending reported balance
After 2026-01-29 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2026-01-29 · Exercise / conversion · Acquired 26,842 · Balance 401,677 F1: Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share. Row 2 · 2026-01-29 · Tax withholding · Disposed 11,368 · Balance 390,309 F2: Shares that were withheld by the issuer to satisfy the reporting person's tax obligation resulting from the vesting of restricted stock units. F3: Per share value is based on the market closing price of the common shares for January 29, 2026. Row 3 · 2026-01-29 · Exercise / conversion · Acquired 8,948 · Balance 399,257 F4: Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one Company common share. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash. Row 4 · 2026-01-29 · Disposition to issuer · Disposed 8,948 · Balance 390,309 F3: Per share value is based on the market closing price of the common shares for January 29, 2026. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Expires 2027-01-29 | Direct | 26,842 |
Reported balance
After 2026-01-29 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-01-29 · Exercise / conversion · Disposed 26,842 · Balance 26,842 F1: Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share. F5: Restricted Stock Units (RSUs) granted to reporting person on January 29, 2024, which vest in three equal annual installments beginning on the first anniversary of the grant date. |
| Phantom Share UnitsSEC Table II · derivative / convertible security · Expires 2027-01-29 | Direct | 8,946 |
Reported balance
After 2026-01-29 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-01-29 · Exercise / conversion · Disposed 8,948 · Balance 8,946 F4: Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one Company common share. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash. F6: Represents an award granted on January 29, 2024 under the Issuer's Phantom Share Unit Plan which vests in three equal annual installments beginning on the first anniversary of the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share.
F2: Shares that were withheld by the issuer to satisfy the reporting person's tax obligation resulting from the vesting of restricted stock units.
F3: Per share value is based on the market closing price of the common shares for January 29, 2026.
F4: Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one Company common share. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash.
F5: Restricted Stock Units (RSUs) granted to reporting person on January 29, 2024, which vest in three equal annual installments beginning on the first anniversary of the grant date.
F6: Represents an award granted on January 29, 2024 under the Issuer's Phantom Share Unit Plan which vests in three equal annual installments beginning on the first anniversary of the grant date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 29, 2026 Filed Feb 2, 2026 22:34 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Exercise / conversionPhantom Share Units · Derivative | 8,948 | $0.00 | $0.00 |
DisclosureSEC source: 0001429216-26-000007 · wk-form4_1770071694.xml · derivative · entry 6 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,946 Underlying: Common Shares · 8,948 shares Expires 2027-01-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one Company common share. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash. F6 · derivative.exercise_date: Represents an award granted on January 29, 2024 under the Issuer's Phantom Share Unit Plan which vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| January 29, 2026 Filed Feb 2, 2026 22:34 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Exercise / conversionRestricted Stock Units · Derivative | 26,842 | $0.00 | $0.00 |
DisclosureSEC source: 0001429216-26-000007 · wk-form4_1770071694.xml · derivative · entry 5 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,842 Underlying: Common Shares · 26,842 shares Expires 2027-01-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share. F5 · derivative.exercise_date: Restricted Stock Units (RSUs) granted to reporting person on January 29, 2024, which vest in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| January 29, 2026 Filed Feb 2, 2026 22:34 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Disposition to issuerCommon Shares | 8,948 | $7.48 | $66,931.04 |
DisclosureSEC source: 0001429216-26-000007 · wk-form4_1770071694.xml · nonDerivative · entry 4 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 390,309 F3 · price: Per share value is based on the market closing price of the common shares for January 29, 2026. Read SEC document |
| January 29, 2026 Filed Feb 2, 2026 22:34 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Exercise / conversionCommon Shares | 8,948 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001429216-26-000007 · wk-form4_1770071694.xml · nonDerivative · entry 3 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 399,257 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · price: Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one Company common share. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash. Read SEC document |
| January 29, 2026 Filed Feb 2, 2026 22:34 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Tax withholdingCommon Shares | 11,368 | $7.48 | $85,032.64 |
DisclosureSEC source: 0001429216-26-000007 · wk-form4_1770071694.xml · nonDerivative · entry 2 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 390,309 F2 · shares: Shares that were withheld by the issuer to satisfy the reporting person's tax obligation resulting from the vesting of restricted stock units. F3 · price: Per share value is based on the market closing price of the common shares for January 29, 2026. Read SEC document |
| January 29, 2026 Filed Feb 2, 2026 22:34 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Exercise / conversionCommon Shares | 26,842 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001429216-26-000007 · wk-form4_1770071694.xml · nonDerivative · entry 1 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 401,677 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share. Read SEC document |
| January 21, 2026 Filed Jan 23, 2026 21:55 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Exercise / conversionPhantom Share Units · Derivative | 8,554 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001429216-26-000004 · wk-form4_1769205349.xml · derivative · entry 6 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,107 Underlying: Common Shares · 8,554 shares Expires 2028-01-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one Company common share. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash. F4 · price: Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one Company common share. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash. F6 · derivative.exercise_date: Represents an award granted on January 21, 2025 under the Issuer's Phantom Share Unit Plan which vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| January 21, 2026 Filed Jan 23, 2026 21:55 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Exercise / conversionRestricted Stock Units · Derivative | 117,548 | $0.00 | $0.00 |
DisclosureSEC source: 0001429216-26-000004 · wk-form4_1769205349.xml · derivative · entry 5 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 235,094 Underlying: Common Shares · 117,548 shares Expires 2028-01-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share. F5 · derivative.exercise_date: Restricted Stock Units (RSUs) granted to reporting person on January 21, 2025, which vest in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| January 21, 2026 Filed Jan 23, 2026 21:55 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Disposition to issuerCommon Shares | 8,554 | $7.49 | $64,069.46 |
DisclosureSEC source: 0001429216-26-000004 · wk-form4_1769205349.xml · nonDerivative · entry 4 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 374,835 F3 · price: Per share value is based on the market closing price of the common shares for January 21, 2026. Read SEC document |
| January 21, 2026 Filed Jan 23, 2026 21:55 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Exercise / conversionCommon Shares | 8,554 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001429216-26-000004 · wk-form4_1769205349.xml · nonDerivative · entry 3 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 383,389 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · price: Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one Company common share. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash. Read SEC document |
| January 21, 2026 Filed Jan 23, 2026 21:55 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Tax withholdingCommon Shares | 35,075 | $7.49 | $262,711.75 |
DisclosureSEC source: 0001429216-26-000004 · wk-form4_1769205349.xml · nonDerivative · entry 2 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 374,835 F2 · shares: Shares that were withheld by the issuer to satisfy the reporting person's tax obligation resulting from the vesting of restricted stock units. F3 · price: Per share value is based on the market closing price of the common shares for January 21, 2026. Read SEC document |
| January 21, 2026 Filed Jan 23, 2026 21:55 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Exercise / conversionCommon Shares | 117,548 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001429216-26-000004 · wk-form4_1769205349.xml · nonDerivative · entry 1 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 409,910 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share. Read SEC document |
| January 19, 2026 Filed Jan 21, 2026 22:02 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | GrantPhantom Share Units · Derivative | 29,690 | $0.00 | $0.00 |
DisclosureSEC source: 0001429216-26-000002 · wk-form4_1769032944.xml · derivative · entry 8 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,690 Underlying: Common Shares · 29,690 shares Expires 2029-01-19 F8 · derivative.exercise_price: Each phantom share represents a right to receive the cash value of one share of the Issuer's common shares which will be determined based on the Issuer's share price on the vesting date. F9 · derivative.exercise_date: Represents an award granted on January 19, 2026 under the Issuer's Phantom Share Unit Plan which vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| January 19, 2026 Filed Jan 21, 2026 22:02 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | GrantRestricted Stock Units · Derivative | 118,759 | $0.00 | $0.00 |
DisclosureSEC source: 0001429216-26-000002 · wk-form4_1769032944.xml · derivative · entry 7 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 118,759 Underlying: Common Shares · 118,759 shares Expires 2029-01-19 F1 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share. F7 · derivative.exercise_date: Restricted Stock Units (RSUs) granted to reporting person on January 19, 2026, which vest in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| January 17, 2026 Filed Jan 21, 2026 22:02 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Exercise / conversionPhantom Share Units · Derivative | 6,735 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001429216-26-000002 · wk-form4_1769032944.xml · derivative · entry 6 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 6,735 shares Expires 2026-01-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one Company common share. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash. F4 · price: Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one Company common share. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash. F6 · derivative.exercise_date: Represents an award granted on January 17, 2023 under the Issuer's Phantom Share Unit Plan which vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| January 17, 2026 Filed Jan 21, 2026 22:02 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Exercise / conversionRestricted Stock Units · Derivative | 26,939 | $0.00 | $0.00 |
DisclosureSEC source: 0001429216-26-000002 · wk-form4_1769032944.xml · derivative · entry 5 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 26,939 shares Expires 2026-01-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share. F5 · derivative.exercise_date: Restricted Stock Units (RSUs) granted to reporting person on January 17, 2023, which vest in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| January 17, 2026 Filed Jan 21, 2026 22:02 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Disposition to issuerCommon Shares | 6,735 | $7.33 | $49,367.55 |
DisclosureSEC source: 0001429216-26-000002 · wk-form4_1769032944.xml · nonDerivative · entry 4 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 292,362 F3 · price: Per share value is based on the market closing price of the common shares for January 16, 2026. Read SEC document |
| January 17, 2026 Filed Jan 21, 2026 22:02 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Exercise / conversionCommon Shares | 6,735 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001429216-26-000002 · wk-form4_1769032944.xml · nonDerivative · entry 3 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 299,097 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · price: Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one Company common share. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash. Read SEC document |
| January 17, 2026 Filed Jan 21, 2026 22:02 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Tax withholdingCommon Shares | 8,550 | $7.33 | $62,671.50 |
DisclosureSEC source: 0001429216-26-000002 · wk-form4_1769032944.xml · nonDerivative · entry 2 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 292,362 F2 · shares: Shares that were withheld by the issuer to satisfy the reporting person's tax obligation resulting from the vesting of restricted stock units. F3 · price: Per share value is based on the market closing price of the common shares for January 16, 2026. Read SEC document |
| January 17, 2026 Filed Jan 21, 2026 22:02 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Exercise / conversionCommon Shares | 26,939 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001429216-26-000002 · wk-form4_1769032944.xml · nonDerivative · entry 1 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 300,912 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share. Read SEC document |
| January 29, 2025 Filed Jan 31, 2025 20:28 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Exercise / conversionPhantom Share Units · Derivative | 8,948 | $0.00 | $0.00 |
DisclosureSEC source: 0001729149-25-000045 · wk-form4_1738355279.xml · derivative · entry 6 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,894 Underlying: Common Shares · 8,948 shares Expires 2027-01-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Each phantom share represents a right to receive the cash value of one share of the Issuer's common shares which will be determined based on the Issuer's share price on the vesting date. F7 · derivative.exercise_date: Represents an award granted on January 29, 2024 under the Issuer's Phantom Share Unit Plan which vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| January 29, 2025 Filed Jan 31, 2025 20:28 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Exercise / conversionRestricted Stock Units · Derivative | 26,843 | $0.00 | $0.00 |
DisclosureSEC source: 0001729149-25-000045 · wk-form4_1738355279.xml · derivative · entry 5 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,684 Underlying: Common Shares · 26,843 shares Expires 2027-01-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share. F5 · derivative.exercise_date: Restricted Stock Units (RSUs) granted to reporting person on January 29, 2024, which vest in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| January 29, 2025 Filed Jan 31, 2025 20:28 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Disposition to issuerCommon Shares | 8,948 | $8.28 | $74,089.44 |
DisclosureSEC source: 0001729149-25-000045 · wk-form4_1738355279.xml · nonDerivative · entry 4 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 273,973 F3 · price: Per share value is based on the market closing price of the common shares for January 29, 2025. Read SEC document |
| January 29, 2025 Filed Jan 31, 2025 20:28 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Exercise / conversionCommon Shares | 8,948 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001729149-25-000045 · wk-form4_1738355279.xml · nonDerivative · entry 3 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 282,921 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · price: Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one Company common share. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash. Read SEC document |
| January 29, 2025 Filed Jan 31, 2025 20:28 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Tax withholdingCommon Shares | 8,147 | $8.28 | $67,457.16 |
DisclosureSEC source: 0001729149-25-000045 · wk-form4_1738355279.xml · nonDerivative · entry 2 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 273,973 F2 · shares: Shares that were withheld by the issuer to satisfy the reporting person's tax obligation resulting from the vesting of restricted stock units. F3 · price: Per share value is based on the market closing price of the common shares for January 29, 2025. Read SEC document |
| January 29, 2025 Filed Jan 31, 2025 20:28 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Exercise / conversionCommon Shares | 26,843 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001729149-25-000045 · wk-form4_1738355279.xml · nonDerivative · entry 1 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 282,120 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share. Read SEC document |
| January 21, 2025 Filed Jan 22, 2025 23:40 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | GrantPhantom Share Units · Derivative | 25,661 | $0.00 | $0.00 |
DisclosureSEC source: 0001729149-25-000019 · wk-form4_1737589236.xml · derivative · entry 11 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,661 Underlying: Common Shares · 25,661 shares Expires 2028-01-21 F9 · derivative.exercise_price: Each phantom share represents a right to receive the cash value of one share of the Issuer's common shares which will be determined based on the Issuer's share price on the vesting date. F10 · derivative.exercise_date: Represents an award granted on January 21, 2025 under the Issuer's Phantom Share Unit Plan which vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| January 21, 2025 Filed Jan 22, 2025 23:40 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | GrantRestricted Stock Units · Derivative | 352,642 | $0.00 | $0.00 |
DisclosureSEC source: 0001729149-25-000019 · wk-form4_1737589236.xml · derivative · entry 10 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 352,642 Underlying: Common Shares · 352,642 shares Expires 2028-01-21 F1 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share. F8 · derivative.exercise_date: Restricted Stock Units (RSUs) granted to reporting person on January 21, 2025, which vest in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| January 18, 2025 Filed Jan 22, 2025 23:40 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Exercise / conversionPhantom Share Units · Derivative | 9,488 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001729149-25-000019 · wk-form4_1737589236.xml · derivative · entry 9 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 9,488 shares Expires 2025-01-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one Company common share. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash. F4 · price: Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one Company common share. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash. F7 · derivative.exercise_date: Represents an award granted on January 18, 2022 under the Issuer's Phantom Share Unit Plan which vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| January 18, 2025 Filed Jan 22, 2025 23:40 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Disposition to issuerCommon Shares | 9,488 | $8.15 | $77,327.20 |
DisclosureSEC source: 0001729149-25-000019 · wk-form4_1737589236.xml · nonDerivative · entry 6 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 242,059 F3 · price: Per share value is based on the market closing price of the common shares for January 17, 2025. Read SEC document |
| January 18, 2025 Filed Jan 22, 2025 23:40 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Exercise / conversionCommon Shares | 9,488 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001729149-25-000019 · wk-form4_1737589236.xml · nonDerivative · entry 5 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 251,547 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · price: Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one Company common share. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash. Read SEC document |
| January 18, 2025 Filed Jan 23, 2025 22:44 UTC Amendment | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Exercise / conversionRestricted Stock Units · Derivative | 18,979 | $0.00 | $0.00 |
DisclosureSEC source: 0001729149-25-000028 · wk-form4a_1737672281.xml · derivative · entry 3 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 18,979 shares Expires 2025-01-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share. F1 · shares: This filing amends the Form 4 originally filed on filed on January 22, 2025, to report the payment of tax liability through the withholding of securities in connection with the vesting of restricted stock units on January 18, 2025. F5 · derivative.exercise_date: Restricted Stock Units (RSUs) granted to reporting person on January 18, 2022, which vest in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| January 18, 2025 Filed Jan 23, 2025 22:44 UTC Amendment | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Tax withholdingCommon Shares | 5,761 | $8.15 | $46,952.15 |
DisclosureSEC source: 0001729149-25-000028 · wk-form4a_1737672281.xml · nonDerivative · entry 2 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 255,277 F1 · shares: This filing amends the Form 4 originally filed on filed on January 22, 2025, to report the payment of tax liability through the withholding of securities in connection with the vesting of restricted stock units on January 18, 2025. F3 · shares: Shares that were withheld by the issuer to satisfy the reporting person's tax obligation resulting from the vesting of restricted stock units. F4 · price: Per share value is based on the market closing price of the common shares for January 17, 2025. Read SEC document |
| January 18, 2025 Filed Jan 23, 2025 22:44 UTC Amendment | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Exercise / conversionCommon Shares | 18,979 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001729149-25-000028 · wk-form4a_1737672281.xml · nonDerivative · entry 1 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 261,038 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This filing amends the Form 4 originally filed on filed on January 22, 2025, to report the payment of tax liability through the withholding of securities in connection with the vesting of restricted stock units on January 18, 2025. F2 · price: Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share. Read SEC document |
| January 17, 2025 Filed Jan 22, 2025 23:40 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Exercise / conversionPhantom Share Units · Derivative | 6,735 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001729149-25-000019 · wk-form4_1737589236.xml · derivative · entry 8 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,735 Underlying: Common Shares · 6,735 shares Expires 2026-01-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one Company common share. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash. F4 · price: Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one Company common share. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash. F6 · derivative.exercise_date: Represents an award granted on January 17, 2023 under the Issuer's Phantom Share Unit Plan which vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| January 17, 2025 Filed Jan 22, 2025 23:40 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Exercise / conversionRestricted Stock Units · Derivative | 26,939 | $0.00 | $0.00 |
DisclosureSEC source: 0001729149-25-000019 · wk-form4_1737589236.xml · derivative · entry 7 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,939 Underlying: Common Shares · 26,939 shares Expires 2026-01-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share. F5 · derivative.exercise_date: Restricted Stock Units (RSUs) granted to reporting person on January 17, 2023, which vest in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| January 17, 2025 Filed Jan 22, 2025 23:40 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Disposition to issuerCommon Shares | 6,735 | $8.15 | $54,890.25 |
DisclosureSEC source: 0001729149-25-000019 · wk-form4_1737589236.xml · nonDerivative · entry 4 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 242,059 F3 · price: Per share value is based on the market closing price of the common shares for January 17, 2025. Read SEC document |
| January 17, 2025 Filed Jan 22, 2025 23:40 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Exercise / conversionCommon Shares | 6,735 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001729149-25-000019 · wk-form4_1737589236.xml · nonDerivative · entry 3 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 248,794 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · price: Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one Company common share. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash. Read SEC document |
| January 17, 2025 Filed Jan 22, 2025 23:40 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Tax withholdingCommon Shares | 8,764 | $8.15 | $71,426.60 |
DisclosureSEC source: 0001729149-25-000019 · wk-form4_1737589236.xml · nonDerivative · entry 2 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 242,059 F2 · shares: Shares that were withheld by the issuer to satisfy the reporting person's tax obligation resulting from the vesting of restricted stock units. F3 · price: Per share value is based on the market closing price of the common shares for January 17, 2025. Read SEC document |
| January 17, 2025 Filed Jan 22, 2025 23:40 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Exercise / conversionCommon Shares | 26,939 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001729149-25-000019 · wk-form4_1737589236.xml · nonDerivative · entry 1 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 250,823 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share. Read SEC document |
| May 09, 2024 Filed May 10, 2024 20:37 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Exercise / conversionPhantom Share Units · Derivative | 3,251 | $0.00 | $0.00 |
DisclosureSEC source: 0001729149-24-000142 · wk-form4_1715373422.xml · derivative · entry 3 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 3,251 shares Expires 2024-05-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each share of phantom stock represents a right to receive the cash value of one share of the Issuer's common shares which will be determined based on the Issuer's share price on the vesting date. F3 · derivative.exercise_date: Represents an award granted in 2021 under the Issuer's Phantom Share Unit Plan which vested on May 9, 2024. Read SEC document |
| May 09, 2024 Filed May 10, 2024 20:37 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Disposition to issuerCommon Shares | 3,251 | $7.13 | $23,179.63 |
DisclosureSEC source: 0001729149-24-000142 · wk-form4_1715373422.xml · nonDerivative · entry 2 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 223,884 Read SEC document |
| May 09, 2024 Filed May 10, 2024 20:37 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Exercise / conversionCommon Shares | 3,251 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001729149-24-000142 · wk-form4_1715373422.xml · nonDerivative · entry 1 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 227,135 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one Company common share. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash. Read SEC document |
| January 29, 2024 Filed Jan 30, 2024 22:51 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | GrantRestricted Stock Units · Derivative | 80,527 | $0.00 | $0.00 |
DisclosureSEC source: 0001729149-24-000066 · wk-form4_1706655054.xml · derivative · entry 2 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,527 Underlying: Common Shares · 80,527 shares Expires 2027-01-29 F3 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share. F4 · derivative.exercise_date: Restricted Stock Units (RSUs) granted to reporting person on January 29, 2024, which vest in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| January 29, 2024 Filed Jan 30, 2024 22:51 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | GrantPhantom Share Units · Derivative | 26,842 | $0.00 | $0.00 |
DisclosureSEC source: 0001729149-24-000066 · wk-form4_1706655054.xml · derivative · entry 1 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,842 Underlying: Common Shares · 26,842 shares Expires 2027-01-29 F1 · derivative.exercise_price: Each phantom share represents a right to receive the cash value of one share of the Issuer's common shares which will be determined based on the Issuer's share price on the vesting date. F2 · derivative.exercise_date: Represents an award granted on January 29, 2024 under the Issuer's Phantom Share Unit Plan which vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| January 18, 2024 Filed Jan 19, 2024 22:50 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Exercise / conversionPhantom Share Units · Derivative | 9,490 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001729149-24-000012 · wk-form4_1705704620.xml · derivative · entry 9 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,488 Underlying: Common Shares · 9,490 shares Expires 2025-01-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one Company common share. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash. F1 · price: Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one Company common share. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash. F8 · derivative.exercise_date: Represents an award granted on January 18, 2022 under the Issuer's Phantom Share Unit Plan which vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| January 18, 2024 Filed Jan 19, 2024 22:50 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Disposition to issuerCommon Shares | 9,490 | $7.62 | $72,313.80 |
DisclosureSEC source: 0001729149-24-000012 · wk-form4_1705704620.xml · nonDerivative · entry 6 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 210,252 F5 · price: Per share value is based on the market closing price of the common shares for January 18, 2024. Read SEC document |
| January 18, 2024 Filed Jan 19, 2024 22:50 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Exercise / conversionCommon Shares | 9,490 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001729149-24-000012 · wk-form4_1705704620.xml · nonDerivative · entry 5 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 219,742 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one Company common share. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash. Read SEC document |
| January 18, 2024 Filed Jan 22, 2024 22:36 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Exercise / conversionRestricted Stock Units · Derivative | 18,979 | $0.00 | $0.00 |
DisclosureSEC source: 0001729149-24-000026 · wk-form4_1705962986.xml · derivative · entry 3 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,979 Underlying: Common Shares · 18,979 shares Expires 2025-01-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share. F4 · derivative.exercise_date: Restricted Stock Units (RSUs) granted to reporting person on January 18, 2022, which vest in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| January 18, 2024 Filed Jan 22, 2024 22:36 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Tax withholdingCommon Shares | 6,667 | $7.62 | $50,802.54 |
DisclosureSEC source: 0001729149-24-000026 · wk-form4_1705962986.xml · nonDerivative · entry 2 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 222,564 F2 · shares: Shares that were withheld by the issuer to satisfy the reporting person's tax obligation resulting from the vesting of restricted stock units. F3 · price: Per share value is based on the market closing price of the common shares for January 18, 2024. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.